arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Adia Nutrition, Inc.

ADIA
— Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
3 Visible periods
24 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Fair
Moderately Bearish
auto_awesome

Analytical Summary

Adia Nutrition, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap —
Dividend Yield —
Revenue Growth 10879.7%
Op. Margin -52.3%
ROIC 142.2% ↗
FCF / Share $-0.00 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

3-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$700.51K
↑ +10879.7% —
Net Income Profit after all expenses
$-395.46K
↓ -118.4% —
FCF / Share Free cash flow per share
$-0.00
↑ +47.2% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
100
Cash Quality ↓
39

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 3 years · 7 quarters